The Procter & Gamble Company
US ˙ NYSE ˙ US7427181091

SecurityPG / The Procter & Gamble Company
InstitutionLockheed Martin Investment Management Co
Latest Disclosed Ownership86,190 shares
Latest Disclosed Value $ 12,449,284
Lockheed Martin Investment Management Co reports 1.04% increase in ownership of PG / The Procter & Gamble Company

On May 6, 2026 - Lockheed Martin Investment Management Co filed a 13F-HR form disclosing ownership of 86,190 shares of The Procter & Gamble Company (US:PG) valued at $12,449,284 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 85,300 shares of The Procter & Gamble Company. This represents a change in shares of 1.04% during the quarter. The current value of the position is $12,630,283 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F PROCTER & GAMBLE COM 742718109 86,190 890 1.04 12,449 1.84 0.4557
2026-02-05 2025-12-31 13F PROCTER AND GAMBLE COM 742718109 85,300 -107,170 -55.68 12,224 -58.66 0.4082
2025-10-30 2025-09-30 13F PROCTER AND GAMBLE COM 742718109 192,470 -56,310 -22.63 29,573 -25.39 1.0892
2025-08-04 2025-06-30 13F PROCTER AND GAMBLE COM 742718109 248,780 132,370 113.71 39,636 99.79 1.4487
2025-05-12 2025-03-31 13F PROCTER AND GAMBLE COM 742718109 116,410 21,610 22.80 19,839 24.82 0.8073
2025-01-27 2024-12-31 13F PROCTER AND GAMBLE COM 742718109 94,800 13,930 17.23 15,893 13.47 0.6331
2024-11-14 2024-09-30 13F PROCTER AND GAMBLE COM 742718109 80,870 4,870 6.41 14,007 11.75 0.6486
2024-08-07 2024-06-30 13F PROCTER AND GAMBLE COM 742718109 76,000 5,450 7.73 12,534 13.88 0.7256
2024-05-13 2024-03-31 13F PROCTER AND GAMBLE COM 742718109 70,550 -23,550 -25.03 11,006 -20.18 0.7989
2024-02-12 2023-12-31 13F PROCTER AND GAMBLE COM 742718109 94,100 -17,250 -15.49 13,788 -14.48 0.9878
2023-11-13 2023-09-30 13F PROCTER AND GAMBLE COM 742718109 111,350 -18,750 -14.41 16,123 -18.33 1.2374
2023-08-14 2023-06-30 13F Procter & Gamble Common Equities 742718109 130,100 69,390 114.30 19,741 118.71 1.1330
2023-05-11 2023-03-31 13F Procter & Gamble Common Equities 742718109 60,710 -36,122 -37.30 9,027 -38.49 0.5114
2023-02-14 2022-12-31 13F/A-1 Procter & Gamble Common Equities 742718109 96,832 3,250 3.47 14,676 24.22 0.9744
2023-02-08 2022-12-31 13F Procter & Gamble Common Equities 742718109 96,832 3,250 15 0.9744
2022-11-03 2022-09-30 13F Procter & Gamble Common Equities 742718109 93,582 0 0.00 11,814 -12.20 0.9502
2022-08-12 2022-06-30 13F Procter & Gamble Common Equities 742718109 93,582 -6,280 -6.29 13,456 -11.81 0.9141
2022-05-12 2022-03-31 13F Procter & Gamble Common Equities 742718109 99,862 8,470 9.27 15,258 2.07 0.8399
2022-02-10 2021-12-31 13F Procter & Gamble Common Equities 742718109 91,392 0 0.00 14,949 17.01 0.8002
2021-11-12 2021-09-30 13F Procter & Gamble Common Equities 742718109 91,392 -2,610 -2.78 12,776 0.73 0.6925
2021-08-06 2021-06-30 13F Procter & Gamble Common Equities 742718109 94,002 -27,070 -22.36 12,683 -22.65 0.6632
2021-05-12 2021-03-31 13F Procter & Gamble Common Equities 742718109 121,072 18,680 18.24 16,396 15.09 0.8385
2021-02-12 2020-12-31 13F/A-1 Procter & Gamble Common Equities 742718109 102,392 -61,300 -37.45 14,246 -37.38 0.7370
2021-02-12 2020-12-31 13F Procter & Gamble Common Equities 742718109 102,392 14,246 0.7370
2020-11-13 2020-09-30 13F Procter & Gamble Common Equities 742718109 163,692 -17,050 -9.43 22,751 5.28 1.4100
2020-07-31 2020-06-30 13F Procter & Gamble Common Equities 742718109 180,742 0 0.00 21,611 8.70 1.4276
2020-04-23 2020-03-31 13F Procter & Gamble Common Equities 742718109 180,742 130,550 260.10 19,881 217.18 1.3561
2020-02-10 2019-12-31 13F Procter & Gamble Common Equities 742718109 50,192 7,872 18.60 6,268 19.10 0.3311
2019-11-14 2019-09-30 13F Procter & Gamble Common Equities 742718109 42,320 -25,580 -37.67 5,263 -29.31 0.3342
2019-08-14 2019-06-30 13F Procter & Gamble Common Equities 742718109 67,900 67,900 7,445 0.3376
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.